Miltenyi Biotec at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Miltenyi Biotec brings 6 presentations to ESGCT 2026 in Hamburg. Its work centres on automated, GMP-compliant processing for cell therapies, including blood stem cell engineering for children and adults. A second strand covers targeted lentiviral vectors for gene transfer in the body and CAR T cells armoured with nanobodies.
| Organization | ESGCT 2026 Attendance |
|---|---|
Miltenyi Biotec Bergisch Gladbach, Germany | ◆Gold Sponsor |
Cell separation pioneer providing instruments, reagents and process development services for cell and gene therapies in cancer, autoimmune and inherited disease. | Poster Wed Oct 28 1:30pm–3:30pm TCR T cells manufactured using a CD8-targeted lentiviral vector Poster Thu Oct 29 2:00pm–4:00pm Armoring GD2-targeted CAR T cells with anti-CD39 activity-blocking nanobodies. Poster Thu Oct 29 2:00pm–4:00pm Automated ex vivo processing enhances lentiviral transduction and preserves stemness processing enhances lentiviral transduction and preserves stemness in human cd34⁺ hematopoietic stem cells Poster Thu Oct 29 2:00pm–4:00pm Development of a GMP-compliant automated hematopoietic stem cell engineering process for pediatric and adult use cases Poster Thu Oct 29 2:00pm–4:00pm Targeted Lentiviral Vectors for Gene Transfer in vivo Poster Thu Oct 29 2:00pm–4:00pm Towards scalable Point-Of-Care HSC gene therapy through automated lipid nanoparticle engineering of CD34+ cells |
Instantly find 20 buyers from Miltenyi Biotec
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction